Risk factors of pneumothorax and pneumomediastinum in covid-19: a matched case-control study

HIGHLIGHTS

  • who: Se Ju Lee from the The Institutional Review Board of the Yonsei University Health System Clinical Trial Centre approved this study on , May , (4-2021-0510)Because the study was retrospective and the data were anonymized, the IRB waived the requirement for informed consent. Variables and definitions have published the research work: Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study, in the Journal: (JOURNAL) of January/31,/2022
  • what: The aim of this matched case-control study was to identify the risk factors and clinical characteristics of PNX . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?